Submitted by Anonymous (not verified) on 8 September 2023 - 9:56
Human medicines European public assessment report (EPAR): Natpar, parathyroid hormone, Hypoparathyroidism, Date of authorisation: 24/04/2017, Revision: 16, Status: Authorised
Source: